Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders
Encouraged by these results, Sekhar has continued his investigations by testing the value of GlyNAC supplementation for improving the health of the growing older population, and has completed an open label trial, and another NIH-funded, double-blind, placebo-controlled trial in older adults
The biphasic response suggests possible mechanisms: lower doses (nanogram range) might work through growth factor upregulation and signaling cascade amplification, while higher doses (microgram range) might involve direct receptor activation or substrate provision for cellular repair
24 Certain mutations paradoxically correlate with ICI resistance despite elevated TMB, highlighting the importance of antigen presentation, mutation type, and immune contexture
Excessive angiogenesis during early surgical healing can complicate scar formation